Identification of HAGHL as a novel metabolic oncogene regulating human colorectal cancer progression.
Yan XuXiaojun ZhouLing GaoSu YanZhenyun LiDaiyi ZhangJianhong PuShitao ZouZhongqi MaoPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2022)
These findings suggest that HAGHL acts as a novel metabolic oncogene and demonstrate the underlying mechanism by which HAGHL regulates CRC progression, highlighting its utility as a diagnostic and prognostic factor and as a potential therapeutic target for the treatment of CRC.